Kindred Biosciences (KIN) Tops Q3 EPS by 8c

Kindred Biosciences (NASDAQ: KIN) reported Q3 EPS of ($0.36), $0.08 better than the analyst estimate of ($0.44).

For earnings history and earnings-related data on Kindred Biosciences (KIN) click here.

You May Also Be Interested In

• Okta upgraded as AI security opportunity boosts outlook
• Performance Food Group (PFGC) Misses Q4 EPS by 1c ; Offers Guidance
• Octave Intelligence plc (OCTV) Tops Q2 EPS by 4c ; Offers Guidance